CONMED Corporation Announces First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CONMED (CNMD) PT Raised to $95 at Needham & Company
April 25, 2019 8:26 AM EDTNeedham & Company analyst Mike Matson raised the price target on CONMED (NASDAQ: CNMD) to $95.00 (from $94.00) while maintaining a Buy rating.
The analyst commented, " CNMD's 1Q19 revenue and EPS beat consensus. Given the recent Buffalo Filter acquisition, management provided 2019 revenue guidance and also raised its... More
Conmed (CNMD) Tops Q1 EPS by 3c; Raises Outlook
April 24, 2019 4:02 PM EDTConmed (NASDAQ: CNMD) reported Q1 EPS of $0.57, $0.03 better than the analyst estimate of $0.54. Revenue for the quarter came in at $218.4 million versus the consensus estimate of $212.99 million.
GUIDANCE:
Conmed sees FY2019 EPS of $2.47-$2.52, from $2.42-$2.47 and the consensus of... More
